000			01646 a2200445 4500
005			20250516073359.0
264		0	_c20120917
008			201209s 0 0 eng d
022			_a1473-1150
024	7		_a10.1038/tpj.2011.53 _2doi
040			_aNLM _beng _cNLM
100	1		_aSanoudou, D
245	0	0	_aArray-based pharmacogenomics of molecular-targeted therapies in oncology. _h[electronic resource]
260			_bThe pharmacogenomics journal _cJun 2012
300			_a185-96 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aEconomics, Pharmaceutical
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aGene Expression Profiling _xmethods
650	0	4	_aGenetic Testing
650	0	4	_aHumans
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aOligonucleotide Array Sequence Analysis
650	0	4	_aPatient Selection
650	0	4	_aPrecision Medicine
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aProto-Oncogene Proteins c-kit _xantagonists & inhibitors
650	0	4	_aReceptor, ErbB-2 _xantagonists & inhibitors
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTreatment Outcome
700	1		_aMountzios, G
700	1		_aArvanitis, D A
700	1		_aPectasides, D
773	0		_tThe pharmacogenomics journal _gvol. 12 _gno. 3 _gp. 185-96
856	4	0	_uhttps://doi.org/10.1038/tpj.2011.53 _zAvailable from publisher's website
999			_c21465033 _d21465033